Medical Affairs – Respiratory Cancer: Updated Trial Data Review and Insights

April 25, 2018Case Study

A leading pharmaceutical organization’s medical affairs team was committed to gathering ongoing actionable insights from oncologists located throughout the United States about the latest trial data for a new combination therapy for treating a type of respiratory cancer. Specifically, they wanted to gather prescribers’ insights to assess their evaluation of ongoing safety and efficacy data and the potential impact to first-line treatment decision-making.

This case study examines how the medical affairs team addressed their objectives.